ADC Therapeutics SA
Stock Forecast, Prediction & Price Target
ADC Therapeutics SA Financial Estimates
ADC Therapeutics SA Revenue Estimates
ADC Therapeutics SA EBITDA Estimates
ADC Therapeutics SA Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $33.91M N/A | $209.90M 518.88% | $69.55M -66.86% | Avg: $90.51M Low: $86.95M High: $93.23M avg. 30.12% | Avg: $119.36M Low: $112.87M High: $124.20M avg. 31.87% | Avg: $202.72M Low: $191.70M High: $210.95M avg. 69.84% | Avg: $308.33M Low: $291.56M High: $320.84M avg. 52.09% |
Net Income
% change YoY
| $-230.02M N/A | $-155.8M 32.26% | $-240.05M -54.07% | Avg: $-171.56M Low: $-158.52M High: $-88.24M avg. 28.52% | Avg: $-161.54M Low: $-139.72M High: $-62.10M avg. 5.83% | Avg: $-70.88M Low: $-74.62M High: $-65.87M avg. 56.12% | Avg: $-15.11M Low: $-15.91M High: $-14.04M avg. 78.67% |
EBITDA
% change YoY
| $-233.16M N/A | $-98.83M 57.61% | $-146.76M -48.49% | Avg: $-44.72M Low: $-46.07M High: $-42.97M avg. 69.52% | Avg: $-58.98M Low: $-61.37M High: $-55.77M avg. -31.87% | Avg: $-100.18M Low: $-104.24M High: $-94.73M avg. -69.84% | Avg: $-152.37M Low: $-158.55M High: $-144.08M avg. -52.09% |
EPS
% change YoY
| -$3 N/A | -$1.99 33.66% | -$2.94 -47.73% | Avg: -$1.58 Low: -$1.94 High: -$1.08 avg. 46.31% | Avg: -$1.37 Low: -$1.71 High: -$0.76 avg. 13.45% | Avg: -$0.87 Low: -$0.91 High: -$0.81 avg. 36.49% | Avg: -$0.19 Low: -$0.19 High: -$0.17 avg. 78.67% |
Operating Expenses
% change YoY
| $294.24M N/A | $328.95M 11.79% | $233.01M -29.16% | Avg: $237.41M Low: $228.08M High: $244.54M avg. 1.88% | Avg: $313.07M Low: $296.05M High: $325.77M avg. 31.87% | Avg: $531.74M Low: $502.82M High: $553.31M avg. 69.84% | Avg: $808.74M Low: $764.76M High: $841.55M avg. 52.09% |
FAQ
What is ADC Therapeutics SA stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 42.29% in 2025-2028.
We have gathered data from 6 analysts. Their low estimate is -158.52M, average is -171.56M and high is -88.24M.
What is ADC Therapeutics SA stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 45.98% in 2025-2028.
We have gathered data from 6 analysts. Their low revenue estimate is $86.95M, average is $90.51M and high is $93.23M.
What is ADC Therapeutics SA stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 43.73% in 2025-2028.
We have gathered data from 6 analysts. Their low earnings per share estimate is -$1.94, average is -$1.58 and high is $-1.08.
What is the best performing analyst?
In the last twelve months analysts have been covering ADC Therapeutics SA stock. The most successful analyst is Robert Burns.